Publications

  1. Leong RW, Butcher RO, Picco MF. Implementation of Image-enhanced Endoscopy into Solo and Group Practices for Dysplasia Detection in Crohn's Disease and Ulcerative Colitis. Gastrointest Endosc Clin N Am. 2014 Jul; 24(3):419-25.
    View PubMed
  2. Wallace MB, Crook JE, Coe S, Ussui V, Staggs E, Almansa C, Patel MK, Bouras E, Cangemi J, Keaveny A, Picco M, Riegert-Johnson D. Accuracy of in vivo colorectal polyp discrimination by using dual-focus high-definition narrow-band imaging colonoscopy. Gastrointest Endosc. 2014 Jun 24.
    View PubMed
  3. Picco MF, Pasha S, Leighton JA, Bruining D, Loftus EV Jr, Thomas CS, Crook JE, Krishna M, Wallace M. Procedure time and the determination of polypoid abnormalities with experience: implementation of a chromoendoscopy program for surveillance colonoscopy for ulcerative colitis. Inflamm Bowel Dis. 2013 Aug; 19(9):1913-20.
    View PubMed
  4. Wang YR, Cangemi JR, Loftus EV Jr, Picco MF. Risk of colorectal cancer after colonoscopy compared with flexible sigmoidoscopy or no lower endoscopy among older patients in the United States, 1998-2005. Mayo Clin Proc. 2013 May; 88(5):464-70. Epub 2013 Mar 21.
    View PubMed
  5. Wang YR, Cangemi JR, Loftus EV Jr, Picco MF. Increased odds of interval left-sided colorectal cancer after flexible sigmoidoscopy compared with colonoscopy in older patients in the United States: a population-based analysis of the SEER-Medicare linked database, 2001-2005. Mayo Clin Proc. 2013 May; 88(5):471-8. Epub 2013 Apr 04.
    View PubMed
  6. Wang YR, Cangemi JR, Loftus EV Jr, Picco MF. Rate of early/missed colorectal cancers after colonoscopy in older patients with or without inflammatory bowel disease in the United States. Am J Gastroenterol. 2013 Mar; 108(3):444-9. Epub 2013 Jan 08.
    View PubMed
  7. Wang YR, Loftus EV Jr, Cangemi JR, Picco MF. Racial/Ethnic and regional differences in the prevalence of inflammatory bowel disease in the United States. Digestion. 2013; 88(1):20-5. Epub 2013 Jun 22
    View PubMed
  8. Gross SA, Buchner AM, Crook JE, Cangemi JR, Picco MF, Wolfsen HC, DeVault KR, Loeb DS, Raimondo M, Woodward TA, Wallace MB. A comparison of high definition-image enhanced colonoscopy and standard white-light colonoscopy for colorectal polyp detection. Endoscopy. 2011 Dec; 43(12):1045-51. Epub 2011 Oct 04.
    View PubMed
  9. Wang YR, Talley NJ, Picco MF. Overlap irritable bowel syndrome, inflammatory bowel disease, and diverticular disease. J Clin Gastroenterol. 2011 Apr; 45(Suppl 1):S36-42.
  10. Buchner AM, Gomez V, Heckman MG, Shahid MW, Achem S, Gill KR, Jamil LH, Kahaleh M, Lo SK, Picco M, Riegert-Johnson D, Raimondo M, Sciemeca D, Wolfsen H, Woodward T, Wallace MB. The learning curve of in vivo probe-based confocal laser endomicroscopy for prediction of colorectal neoplasia. Gastrointest Endosc. 2011 Mar; 73(3):556-60.
    View PubMed
  11. Picco MF, Zubiaurre I, Adluni M, Cangemi JR, Shelton D. Immunomodulators are associated with a lower risk of first surgery among patients with non-penetrating non-stricturing Crohn's disease. Am J Gastroenterol. 2009 Nov; 104(11):2754-9. Epub 2009 Jul 07.
    View PubMed
  12. Cangemi JR, Picco MF. Intestinal ischemia in the elderly. Gastroenterol Clin North Am. 2009 Sep; 38(3):527-40.
    View PubMed
  13. Picco MF, Cangemi JR. Inflammatory bowel disease in the elderly. Gastroenterol Clin North Am. 2009 Sep; 38(3):447-62.
    View PubMed
  14. Edula RG, Picco MF. An evidence-based review of natalizumab therapy in the management of Crohn's disease. Ther Clin Risk Manag. 2009; 5:935-42.
    View PubMed
  15. Isaacs KL, Sandler RS, Abreu M, Picco MF, Hanauer SB, Bickston SJ, Present D, Farraye FA, Wolf D, Sandborn WJ, Crohn's and Colitis Foundation of America Clinical Alliance. Rifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis. 2007 Oct; 13(10):1250-5.
    View PubMed
  16. Picco MF, Krishna M, Cangemi JR, Shelton D. Oral mesalamine and clinical remission are associated with a decrease in the extent of long-standing ulcerative colitis. Inflamm Bowel Dis. 2006 Jul; 12(7):537-42.
    View PubMed
  17. Sachar DB, Bodian CA, Goldstein ES, Present DH, Bayless TM, Picco M, van Hogezand RA, Annese V, Schneider J, Korelitz BI, Cosnes J, Task Force on Clinical Phenotyping of the IOIBD. Is perianal Crohn's disease associated with intestinal fistulization? Am J Gastroenterol. 2005 Jul; 100(7):1547-9.
    View PubMed
  18. Brant SR, Picco MF, Achkar JP, Bayless TM, Kane SV, Brzezinski A, Nouvet FJ, Bonen D, Karban A, Dassopoulos T, Karaliukas R, Beaty TH, Hanauer SB, Duerr RH, Cho JH. Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's disease phenotypes. Inflamm Bowel Dis. 2003 Sep; 9(5):281-9.
    View PubMed
  19. Picco MF, Bayless TM. Tobacco consumption and disease duration are associated with fistulizing and stricturing behaviors in the first 8 years of Crohn's disease. Am J Gastroenterol. 2003 Feb; 98(2):363-8.
    View PubMed
  20. Lukens FJ, Loeb DS, Machicao VI, Achem SR, Picco MF. Colonoscopy in octogenarians: a prospective outpatient study. Am J Gastroenterol. 2002 Jul; 97(7):1722-5.
    View PubMed
  21. Scolapio JS, Picco MF, Tarrosa VB. Enteral versus parenteral nutrition: the patient's preference. JPEN J Parenter Enteral Nutr. 2002 Jul-Aug; 26(4):248-50.
    View PubMed
  22. Picco MF. Crohn's disease: rational management. Consultant. 2002 Feb; 42(2):185-8, 191-4, 197.
    View PubMed
  23. Picco MF. Crohn Disease: A rational approach to management. Drug Benefit Trends. 2002; 14(Suppl. A):25-33.
    View PubMed
  24. Picco MF, Goodman S, Reed J, Bayless TM. Methodologic pitfalls in the determination of genetic anticipation: the case of Crohn disease. Ann Intern Med. 2001 Jun 19; 134(12):1124-9.
    View PubMed
  25. Picco MF. Ulcerative colitis: a rational approach to management. Consultant. 2001; 41(4):541-548.
    View PubMed